Advanced Biomed Inc., a Nevada-based company, has announced a new shareholder agreement with Helena Global Investment Opportunities I Ltd. The agreement, dated June 6, 2025, grants Advanced Biomed the right to issue and sell up to $25 million of its common stock to Helena Global. The common stock will be traded under the symbol "ADVB" on the Nasdaq Capital Markets. This strategic move is expected to bolster Advanced Biomed's financial position and support its ongoing growth initiatives. Helena Global, represented by Managing Partner Jeremy Weech, will play a significant role as an investor in this collaboration.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.